StockData
RenovoRx, Inc. logo

RenovoRx, Inc. (RNXT) stock

RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.12+0.08 (+7.69%)

Close on Nov 18, 2026Market cap $50.55MP/E –Yield –

RenovoRx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

RenovoRx's shares outstanding was 47M at Jun 30, 2026. For fiscal 2025 it was 35M, up 58.6% from the year before. The highest annual figure on record is 35M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202535M+58.6%
FY2024Dec 31, 202422M+116.4%
FY2023Dec 31, 202310M+13.7%
FY2022Dec 31, 20229M+73.5%
FY2021Dec 31, 20215M+135.6%
FY2020Dec 31, 20202M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202647M+29.3%
Q1 FY2026Mar 31, 202638M+21.1%
Q4 FY2025Dec 31, 202537M+46.0%
Q3 FY2025Sep 30, 202537M+46.9%
Q2 FY2025Jun 30, 202537M+52.1%
Q1 FY2025Mar 31, 202531M+110.0%
Q4 FY2024Dec 31, 202425M+134.7%
Q3 FY2024Sep 30, 202425M+133.2%
Q2 FY2024Jun 30, 202424M+125.7%
Q1 FY2024Mar 31, 202415M+64.4%
Q4 FY2023Dec 31, 202311M+17.7%
Q3 FY2023Sep 30, 202311M+17.9%
Q2 FY2023Jun 30, 202311M+17.6%
Q1 FY2023Mar 31, 20239M+1.1%
Q4 FY2022Dec 31, 20229M-8.6%
Q3 FY2022Sep 30, 20229M+61.3%
Q2 FY2022Jun 30, 20229M+296.4%
Q1 FY2022Mar 31, 20229M+301.1%
Q4 FY2021Dec 31, 202110M+361.5%
Q3 FY2021Sep 30, 20216M+148.3%
Q2 FY2021Jun 30, 20212M–
Q1 FY2021Mar 31, 20212M–
Q4 FY2020Dec 31, 20202M–
Q3 FY2020Sep 30, 20202M–

More RenovoRx figures

See a number that looks wrong?